Black Diamond Therapeutics, Inc.
BDTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001701541
No open-market purchases or sales by Black Diamond Therapeutics, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $64.9M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Black Diamond Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- −8 vs. Q4 2022
- Shares held
- 21.5M
- +438.8K (+2.1%) vs. Q4 2022
- Total value
- $40.6M
- +$2.72M (+7.2%) vs. Q4 2022
- New holders
- 1
- 8 more added
- Sold out
- 9
- 17 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 96 | $64.9M |
| Q1 2026 | 104 | $82.0M |
| Q4 2025 | 104 | $92.0M |
| Q3 2025 | 91 | $147.0M |
| Q2 2025 | 94 | $95.8M |
| Q1 2025 | 85 | $63.0M |
| Q4 2024 | 88 | $102.5M |
| Q3 2024 | 96 | $211.9M |
| Q2 2024 | 90 | $217.9M |
| Q1 2024 | 88 | $199.9M |
| Q4 2023 | 76 | $107.1M |
| Q3 2023 | 73 | $106.8M |
| Q2 2023 | 74 | $209.2M |
| Q1 2023 | 50 | $40.6M |
| Q4 2022 | 59 | $37.9M |
| Q3 2022 | 69 | $36.3M |
| Q2 2022 | 74 | $52.9M |
| Q1 2022 | 87 | $63.5M |
| Q4 2021 | 95 | $123.7M |
| Q3 2021 | 101 | $206.3M |
| Q2 2021 | 102 | $309.6M |
| Q1 2021 | 113 | $705.5M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Black Diamond Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bellevue Group AG | 5,395,839 | $10.2M | 0.15% | −5,000−0.1% | Reduced |
| NEA Management Company, LLC | 3,448,757 | $6.52M | 0.45% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 2,589,904 | $4.89M | 0.11% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,014,858 | $3.81M | 0.19% | 00.0% | Unchanged |
| Artal Group S.A. | 1,646,517 | $3.11M | 0.18% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 1,191,094 | $2.25M | 0.07% | +908,963+322.2% | Added |
| Millennium Management LLC | 776,594 | $1.47M | 0.00% | +252,037+48.0% | Added |
| Vanguard Group Inc | 757,585 | $1.43M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 756,387 | $1.43M | 0.00% | −237,382−23.9% | Reduced |
| Citadel Advisors LLC | 557,771 | $1.05M | 0.00% | −216,027−27.9% | Reduced |
| Verition Fund Management LLC | 344,307 | $650.7K | 0.01% | +344,307 | New |
| Newtyn Management, LLC | 306,609 | $579.5K | 0.11% | −8,391−2.7% | Reduced |
| Geode Capital Management, LLC | 270,428 | $511.1K | 0.00% | +5,138+1.9% | Added |
| Renaissance Technologies LLC | 217,500 | $411.0K | 0.00% | −3,113−1.4% | Reduced |
| Two Sigma Advisers, LP | 175,900 | $332.5K | 0.00% | −36,600−17.2% | Reduced |
| MPM Oncology Impact Management LP | 144,888 | $273.8K | 0.07% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 131,990 | $249.5K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 107,754 | $203.7K | 0.00% | −35,910−25.0% | Reduced |
| Susquehanna International Group, LLP | 107,733 | $203.6K | 0.00% | +41,919+63.7% | Added |
| State Street Corp | 76,384 | $144.4K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 75,000 | $141.8K | 0.00% | −50,000−40.0% | Reduced |
| Acadian Asset Management LLC | 53,365 | $99.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 37,983 | $71.8K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 36,679 | $69.3K | 0.00% | −327−0.9% | Reduced |
| AE Wealth Management LLC | 35,920 | $67.9K | 0.00% | −27−0.1% | Reduced |
| Beacon Capital Management, LLC | 35,615 | $67.3K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 27,974 | $52.9K | 0.00% | −3,228−10.3% | Reduced |
| Dimensional Fund Advisors LP | 25,920 | $49.0K | 0.00% | −26,602−50.6% | Reduced |
| HSBC Holdings PLC | 24,156 | $44.9K | 0.00% | 00.0% | Unchanged |
| State of Wisconsin Investment Board | 20,500 | $38.7K | 0.00% | −20,700−50.2% | Reduced |
| Barclays PLC | 19,351 | $36.6K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 18,191 | $34.4K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 13,185 | $24.9K | 0.00% | −142,034−91.5% | Reduced |
| Bank of America Corp | 12,789 | $24.2K | 0.00% | −25−0.2% | Reduced |
| K2 Principal Fund, L.P. | 11,316 | $21.4K | 0.01% | −146,876−92.8% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 11,231 | $21.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,627 | $15.0K | 0.00% | +4,162+120.1% | Added |
| Advisor Group Holdings, Inc. | 4,002 | $6.84K | 0.00% | +1,220+43.9% | Added |
| US Bancorp | 700 | $1.32K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 641 | $1.21K | 0.00% | +402+168.2% | Added |
| JPMorgan Chase & Co | 552 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 280 | $529 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 84 | $158 | 0.00% | +75+833.3% | Added |
| Beaird Harris Wealth Management, LLC | 36 | $69 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 35 | $67 | 0.00% | 00.0% | Unchanged |
| New England Capital Financial Advisors LLC | 24 | $46 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 17 | $32 | 0.00% | −96−85.0% | Reduced |
| Royal Bank of Canada | 195 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −97,500−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −34,400−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −20,212−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −17,295−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,914−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,433−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −1,201−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Investors Research Corp | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| CoreCap Advisors, LLC | – | – | – | – | Not filed |